Reply to Visit‐to‐Visit Blood Pressure Variation: Time to Reanalyze All The Data From the TROPHY Study
dc.contributor.author | Julius, Stevo | en_US |
dc.contributor.author | Kaciroti, Niko | en_US |
dc.contributor.author | Oparil, Suzanne | en_US |
dc.date.accessioned | 2013-05-02T19:34:56Z | |
dc.date.available | 2014-05-23T15:04:20Z | en_US |
dc.date.issued | 2013-04 | en_US |
dc.identifier.citation | Julius, Stevo; Kaciroti, Niko; Oparil, Suzanne (2013). "Reply to Visit‐to‐Visit Blood Pressure Variation: Time to Reanalyze All The Data From the TROPHY Study." The Journal of Clinical Hypertension 15(4): 301-301. <http://hdl.handle.net/2027.42/97448> | en_US |
dc.identifier.issn | 1524-6175 | en_US |
dc.identifier.issn | 1751-7176 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/97448 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.title | Reply to Visit‐to‐Visit Blood Pressure Variation: Time to Reanalyze All The Data From the TROPHY Study | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 23551736 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/97448/1/jch12069.pdf | |
dc.identifier.doi | 10.1111/jch.12069 | en_US |
dc.identifier.source | The Journal of Clinical Hypertension | en_US |
dc.identifier.citedreference | Julius S, Nesbitt S, Egan B, et al. Feasibility of treating prehypertension with an angiotensin‐receptor blocker. N Engl J Med 2006; 354: 1685 – 1697. | en_US |
dc.identifier.citedreference | Sasamura H, Nakaya H, Julius S, et al, STAR CAST Investigators. The short treatment with the angiotensin receptor blocker candesartan surveyed by telemedicine (STAR CAST) study: rationale and study design. Hypertens Res 2008; 31: 1843 – 1849. | en_US |
dc.identifier.citedreference | Zhang Y. Lessons from additional trials (CHINOM, PHARAO and STRONG HEART). Plenary Session 4: Clinical Trials in Prehypertension. http://www.prehypertension.org/2011/images/stories/pdf/plenary_session_4.pdf | en_US |
dc.identifier.citedreference | Fuchs FD, Fuchs SC, Moreira LB, et al. Prevention of hypertension in patients with pre‐hypertension: protocol for the PREVER‐prevention trial. Trials 2011; 5: 12. | en_US |
dc.identifier.citedreference | Julius S, Kaciroti N, Nesbitt S, et al, for the Trial of Preventing Hypertension (TROPHY) investigators. TROPHY study: outcomes based on the JNC 7 definition of hypertension. J Am Soc Hypertens 2008; 2: 39 – 43. | en_US |
dc.identifier.citedreference | Kaciroti N, Schork MA, Raghunathan TE, Julius S. A Bayesian sensitivity model for intention‐to‐treat analysis of binary outcomes with dropouts. Stat Med 2009; 28: 572 – 575. | en_US |
dc.identifier.citedreference | Kaciroti N, Raghunathan TE, Taylor J, Julius S. A Bayesian model for discrete time‐to‐event data with informative censoring. Biostatistics 2012; 13: 341 – 354. | en_US |
dc.identifier.citedreference | Levitan EB, Kaciroti N, Oparil S, et al. Blood pressure measurement device, number and timing of visits, and intra‐individual visit‐to‐visit variability of blood pressure. J Clin Hypertens (Greenwich) 2012; 14: 744 – 750. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.